Informationen: Aufgrund von gesteigerten Botaktivitäten, waren wir leider gezwungen, die Suche hinter einen Login zu stellen. Links zu Formularen können weiterhin mit anderen geteilt und ohne Login angeschaut werden. Vielen Dank für Ihr Verständnis.
Informationen:
Fehler:
ID
21170
Beschreibung
Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis; ODM derived from: https://clinicaltrials.gov/show/NCT00615173
Link
https://clinicaltrials.gov/show/NCT00615173
Stichworte
Versionen (1)
- 12.04.17 12.04.17 -
Hochgeladen am
12. April 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Kidney Diseases NCT00615173
Eligibility Kidney Diseases NCT00615173
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Kidney Diseases NCT00615173
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
1. subjects of either sex, 14-65 years of age;
boolean
C0001779 (UMLS CUI [1])
Lupus Erythematosus, Systemic
Item
2. diagnosis of sle according to the acr criteria(1997);
boolean
C0024141 (UMLS CUI [1])
Kidney biopsy | Lupus Nephritis Classification
Item
3. kidney biopsy within the 6 months prior to first randomization with a histologic diagnosis (isn/rps 2003 classification of ln) class iii, iv, v;
boolean
C0194073 (UMLS CUI [1])
C0024143 (UMLS CUI [2,1])
C0008902 (UMLS CUI [2,2])
C0024143 (UMLS CUI [2,1])
C0008902 (UMLS CUI [2,2])
Lupus Nephritis Classification | Proteinuria | Creatinine measurement, serum
Item
4. class iv ln: proteinuria >1g/24hr or scr>115umol/l;
boolean
C0024143 (UMLS CUI [1,1])
C0008902 (UMLS CUI [1,2])
C0033687 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0008902 (UMLS CUI [1,2])
C0033687 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
Lupus Nephritis Classification | Proteinuria | Creatinine measurement, serum
Item
5. class iii or v ln: proteinuria >2g/24hr or scr>115umol/l;
boolean
C0024143 (UMLS CUI [1,1])
C0008902 (UMLS CUI [1,2])
C0033687 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0008902 (UMLS CUI [1,2])
C0033687 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
Informed Consent | Informed Consent Guardian
Item
6. provision of written informed consent by subject or guardian.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C1274041 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,1])
C1274041 (UMLS CUI [2,2])
Informed Consent Unable | Informed Consent Unwilling
Item
1. inability or unwillingness to provide written informed consent ;
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Hypersensitivity Tacrolimus | Medical contraindication Tacrolimus | Hypersensitivity Cyclophosphamide | Medical contraindication Cyclophosphamide | Azathioprine allergy | Medical contraindication Azathioprine | Corticosteroids allergy | Medical contraindication Adrenal Cortex Hormones
Item
2. known hypersensitivity or contraindication to tacrolimus, cyclophosphamide , azathioprine, corticosteroids;
boolean
C0020517 (UMLS CUI [1,1])
C0085149 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0085149 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0010583 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0010583 (UMLS CUI [4,2])
C0570721 (UMLS CUI [5])
C1301624 (UMLS CUI [6,1])
C0004482 (UMLS CUI [6,2])
C0571586 (UMLS CUI [7])
C1301624 (UMLS CUI [8,1])
C0001617 (UMLS CUI [8,2])
C0085149 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0085149 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0010583 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0010583 (UMLS CUI [4,2])
C0570721 (UMLS CUI [5])
C1301624 (UMLS CUI [6,1])
C0004482 (UMLS CUI [6,2])
C0571586 (UMLS CUI [7])
C1301624 (UMLS CUI [8,1])
C0001617 (UMLS CUI [8,2])
Therapeutic immunosuppression | mycophenolate mofetil | Cyclophosphamide | Cyclosporine | Methotrexate
Item
3. usage of immunosuppression therapy (mmf, ctx, cysa, mtx ect) for more than 1 week within 1 month prior to first randomization;
boolean
C0021079 (UMLS CUI [1])
C0209368 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
C0025677 (UMLS CUI [5])
C0209368 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
C0025677 (UMLS CUI [5])
Pregnancy | Breast Feeding | Contraceptive methods Inadequate
Item
4. pregnancy, nursing or use of a non-reliable method of contraception;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3,1])
C0205412 (UMLS CUI [3,2])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3,1])
C0205412 (UMLS CUI [3,2])
Dialysis Continuous
Item
5. continuous dialysis starting more than 2 weeks before randomization into the induction phase and/or continuous dialysis with an anticipated duration of more than 8 weeks;
boolean
C0011946 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
Kidney Transplant | Kidney Transplant Planned
Item
6. previous kidney transplant or planted transplant;
boolean
C0022671 (UMLS CUI [1])
C0022671 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0022671 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
Creatinine measurement, serum
Item
7. scr > 4mg/dl (353umol/l);
boolean
C0201976 (UMLS CUI [1])
Hepatitis | Liver Dysfunction
Item
8. active hepatitis, with liver dysfunction;
boolean
C0019158 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
C0086565 (UMLS CUI [2])
Diabetes Mellitus
Item
9. diagnosed dm;
boolean
C0011849 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs
Item
10. participation in another clinic trial and/or receipt of investigational drugs within 4 weeks prior to screening .
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])